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Objective: To investigate risk factors and distribution of pathogens for 
pulmonary infection in patients with severe acute pancreatitis. Methods: 
The clinical data of 285 patients with severe acute pancreatitis were ret-
rospectively analyzed. Sputum specimens of patients with lung infections 
were studied. Univariate analysis and logistic regression were performed 
to screening the factors correlating to lung infections. Results: Gram-neg-
ative bacilli were the principal microorganisms isolated from those lung 
infections, and these bacterial pathogens demonstrated a marked pattern of 
antibiotic resistance. It was identified that age (OR 1.05, 95% CI 1.01-1.09, 
p=0.01), Ranson scores (OR 3.01 , 95% CI 1.13-8.03, p = 0.03) and surgi-
cal treatment  (OR4.27, 95% CI 1.03-17.65, p = 0.04)were independent risk 
factors of lung infections in patients with severe acute pancreatitis. Con-
clusion: Analysis of pathogen spectrum and drug sensitivity will contribute 
to choosing antibiotics empirically. And preventive measures aimed at risk 
factors could help reduce the incidence of lung infections in patients with 













Acute pancreatitis (AP) is a common acute abdo-
men, the incidence of AP in the world is 10~80 cas-
es /100000 people, the overall mortality in clinic is 
5%~10%, and the mortality in severe cases can be as 
high as 30%[1-2]. The common causes include drinking 
alcohol and gallstones[3]. 15-20% of which are severe 
acute pancreatitis (SAP). SAP progresses rapidly with 
many complications, making it difficult to treat[4]. Since 
there is damage to acinar cells in the AP, it may cause 
multiple organ dysfunction syndrome (MODS)[5] in the 
acute phase of the disease, while in the middle and late 
stage of the disease, the extra-pancreatic tissue infec-
tion is caused by the displacement of intestinal bacteria 
(Extrapancreaticinfec-tions, EPI) [6].With the progress 
of SAP treatment, the number of early deaths due to or-
gan dysfunction has gradually decreased. Infection-re-
lated complications have become the main cause of 
death in SAP patients. The results of many retrospec-
tive studies show that the clinical mortality of infected 
patients is significantly different from that of those with 
no infection, so infection has a great influence on the 
prognosis of AP patients, especially SAP patients[7-9].
Among them, lung infection is a common infection-re-
lated complication, whose incidence is as high as 11% 
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-30%[10], seriously affecting the treatment and progno-
sis of SAP patients[11]. The reason why SAP is prone to 
lung infection may be related to decreased immunity 
and the damage of endothelial cells and alveolar epi-
thelial cells caused by excessive activation of inflam-
matory molecules[12]. SAP patients’ lung infections are 
mostly hospital-acquired pneumonia, and prevention 
should be stressed. Finding out the risk factors of lung 
infection will help us to take targeted preventive mea-
sures to reduce the occurrence of it. Understanding the 
distribution of pathogenic bacteria in lung infections 
complicated by SAP is of great significance to the em-
pirical medication of lung infections.
This paper conducts a retrospective analysis of 285 
SAP patients in the Second Affiliated Hospital of Kun-
ming Medical University from June 1992 to June 2017, 
aiming to provide constructive opinions for future clinical 




285 SAP patients in the Second Affiliated Hospital of 
Kunming Medical University from June 1992 to June 
2017 were selected. The diagnostic criteria for SAP are 
based on the “Guidelines for the Diagnosis and Treatment 
of Acute Pancreatitis in China (2013, Shanghai)” by the 
Pancreatic Disease Group of the Chinese Medical Associ-
ation Digestive Disease Branch [13]. The diagnostic criteria 
for lung infection adopt the “Diagnostic Criteria for Noso-
comial Infection” approved by the Chinese Lung Infection 
Administrative Association [14]. Patients with incomplete 
clinical data were excluded.
2.2 Research Method
① Summarize the incidence of lung infection and its 
mortality among the included cases. ② Bacterial spec-
trum analysis: The strains were derived from the sputum 
culturing results of the included patients with lung infec-
tion, and were identified by the French Mérieux Vitek 32 
automatic bacterial identification instrument. For drug 
susceptibility testing, the K-B disc method was used. As 
for the diagnostic criteria for drug resistance, the stan-
dards of the National Committee for Clinical Laboratory 
Standardization (NCCLS) were adopted. ③ Analyze the 
risk factors of lung infection in the patients. 52 of the 
285 SAP patients had lung infection, and they made up 
the case group. The control group, consisting of 52 cases 
without lung infection, were randomly selected from the 
rest 233 patients. 16 risk factors were chosen based on 
relevant literature reports and clinical experience: gen-
der, age, body mass index (BMI), Ranson score at ad-
mission, history of smoking (smoking for more than 10 
years), history of drinking (drinking every day for more 
than 5 years), history of chronic obstructive pulmonary 
disease (COPD), history of hypertension, history of di-
abetes, blood amylase level at admission, urea nitrogen 
level at admission, albumin level at admission, ventilator 
treatment, indwelling gastric tube for more than 10 days, 
surgical treatment, and hormone therapy. SPSS13.0 soft-
ware was applied to statistical analysis. Measurement 
data was expressed as mean plus or minus standard de-
viation, and counting data was expressed as percentage. 
Measurement data and counting data respectively used 
t test and χ2 test to compare the differences between the 
case group and the control group, looking for factors 
related to infection. Single-factor analysis of statistically 
significant risk factors was followed by logistic regres-
sion analysis, and then multi-factor analysis was used 
to further find independent risk factors related to lung 
infection.
3.Results
3.1 Incidence and Mortality of SAP Patients’ 
Lung Infection
Lung infection occurred in 52 of the 285 SAP patients, 
with an incidence rate of 18.25%. There were 11 deaths 
among patients with lung infection, with a mortality rate 
of 21.15%. Among the 233 SAP patients without lung 
infection, 24 died, with a mortality rate of 10.30%. The 
difference between the two groups was statistically signif-
icant (P ﹤ 0.05).
3.2 Distribution and Drug Sensitivity of Patho-
genic Bacteria in SAP Patients’ Lung Infection 
A total of 56 pathogens were isolated from the sputum 
samples of 45 out of 52 patients with lung infections. One 
pathogen was found in 30 patients, and mixed infection of 
two or more pathogens was found in 15 patients (33.33%). 
Among them, gram-negative bacteria, gram-positive bac-
teria and fungi respectively accounted for 80.36% (45/56), 
12.50% (7/56) and 7.14% (4/56). The common pathogens 
of gram-negative bacteria are Escherichia coli, Pseudo-
monas aeruginosa, Klebsiella pneumoniae, Acinetobacter 
and Enterobacter cloacae in sequence; the pathogens of 
gram-positive bacteria are staphylococcus aureus and 
coagulase-negative staphylococci; fungal pathogens are 
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Table 1. Distribution and constituent ratio of pathogens of 
pulmonary infection in patients with severe acute pancre-
atitis (%) 
Pathogens Number of plants Composition ratio
Gram-negative bacterium 45 80.36
Escherichia coli 14 25.00
Pseudomonas aeruginosa 11 19.64
Klebsiella pneumoniae 10 17.86
Acinetobacter 7 12.50
Enterobacter cloacae 2 3.75
Bacillus maltophilia 1 1.79
Gram-positive bacteria 7 12.5
Staphylococcus aureus 5 8.93
Coagulase-negative staphylococci 2 3.57
Fungi 4 7.14
Candida albicans 3 5.36
Candida smooth 1 1.79
The isolated common pathogens were tested for an-
tibiotic sensitivity, and the results are shown in Table 2. 
Gram-negative bacteria are resistant to common antibi-
otics to varying degrees. Pseudomonas aeruginosa is the 
most resistant, showing a certain degree of resistance to 
imipenem.
Table 2. Resistant rates of major gram-negative bacteria 
























Ampicillin 14 100.00 11 100.00 10 100.00
Piperacillin/
tazobactam 3 21.43 7 63.64 5 50.00
Amikacin 4 28.57 7 63.64 6 60.00
Ciprofloxacin 9 64.29 10 90.90 7 70.00
Cefazolin 10 71.43 11 100.00 8 80.00




2 14.29 6 54.55 4 40.00
Imipenem 0 0.00 5 45.45 2 20.00
3.3 Analysis of Risk Factors for Lung Infection in 
SAP Patients
In order to determine the risk factors of lung infection 
in SAP patients, we selected 16 relevant factors for statis-
tical comparison and analysis between the control group 
and the case group. There were statistical differences in 
7 variables, namely age, ventilator treatment, Ranson 
score at admission, surgical treatment, indwelling naso-
gastric tube for more than 10 days, urea nitrogen level at 
admission and albumin level at admission. The results are 
shown in Tables 3 and 4. In order to exclude relevant risk 
factors, variables were included in a multivariate logistic 
regression analysis, and three variables were determined 
to be independent risk factors for lung infection in SAP 
patients. The results are shown in Table 5, which are re-
spectively age (OR 1.05, 95% CI 1.01 -1.09, p = 0.01), 
Ranson score (OR3.01, 95% CI 1.13-8.03, p = 0.03) and 
surgical treatment (OR4.27, 95% CI 1.03-17.65, p = 0.04).
Table 3. Univariate analysis of risk factors of pulmonary 










Age (years) 50.98 14.62 41.38  14.13 3.403 0.00
BMI (kg/m2) 25.51 3.05   25.11 3.33 0.645 0.52
Ranson score (score) 4.35 0.68 3.75 0.65 4.550 0.00
Blood amylase (U/L) 780.77 327.11 762.88 366.25 0.263 0.79
urea nitrogen (mmol/L) 7.12 1.76 6.27 2.00 2.314 0.02
Albumin (g/L) 37.36 5.00 39.69 6.00 -2.151 0.03
Table 4. Risk factors and infection rates(%) of pulmonary 













2 value P value
Gender
Male 59 31 52.54
0.35 0.69
Female 45 21 46.67
COPD
Yes 11 7 63.64
0.92 0.53




Yes 32 19 59.38
1.63 0.29




Yes 29 13 44.83
0.43 0.66




Yes 19 12 63.16
1.61 0.31
No 85 40 47.59
Diabetes 
history
Yes 14 8 57.14
0.33 0.78




Yes 31 21 67.74
5.56 0.03
No 73 31 42.47
Surgical 
treatment
Yes 21 17 80.95
10.08 0.00






Yes 52 32 61.54
5.54 0.03
No 52 20 38.46
Hormone 
use
Yes 19 11 57.89
0.58 0.61
No 85 41 48.24
DOI: https://doi.org/10.30564/jams.v4i1.2848
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Table 5. Logistic regression analysis of risk factors for 
pulmonary infection in patients with severe acute pancre-
atitis
 β  SE Wald/χ2 p value OR 95%CI
Age 0.05 0.02 6.67 0.01 1.05 1.01-1.09
Ranson score 1.10 0.50 4.86 0.03 3.01 1.13-8.03
Surgical treatment 1.45 0.72 4.02 0.04 4.27 1.03-17.65
4. Discussion
SAP is a serious disease with high prevalence and mor-
tality. It is prone to multiple organ complications, among 
which the incidence of pulmonary complications is as 
high as 68.1% [15]. Lung infection is the main pulmonary 
complication of SAP and an important cause of death in 
SAP patients. The incidence of lung infection in our group 
of cases was as high as 18.25%. The mortality rate of pa-
tients with lung infection was 21.15%, which was higher 
than that of the non-infected group. Therefore, active 
treatment and prevention of lung infection are beneficial 
to reduce the mortality of SAP.
Lung infections of SAP patients are mostly hospital-ac-
quired. Empirical initial antibiotic treatment for hospi-
tal-acquired infections is the main factor determining the 
prognosis of patients. And bacterial resistance testing is an 
important basis for empirical initial antibiotic treatment. 
In etiology, the proportion of Gram-negative bacteria 
was relatively high, which was consistent with that of 
Chen Zhongjian[16]. This study has found that the bacterial 
spectrum of the case group has the following characteris-
tics: ① The pathogenic bacteria are mainly gram-negative 
bacteria, and the infection of gram-negative bacteria may 
be related to endogenous infections such as bacterial 
translocation and inhalation of oropharyngeal secre-
tions. ② The detection rate of multi-drug resistant bacte-
ria is high. Also, the distribution ratio of Pseudomonas 
aeruginosa is high, showing strong antibiotic resistance. 
③ The proportion of mixed infections is high, and about 
1/3 of patients have two or more bacterial infections. SAP 
complicated by lung infection is prone to complications 
such as metabolic disorders and respiratory failure; the 
disease progresses fast with high mortality rate; there are 
a number of risk factors for multidrug-resistant bacteria 
infection with high infection rate. Considering the above 
points, it is appropriate to employ broad-spectrum anti-
biotic therapy, targeted at multi-drug resistant bacteria, 
for empirical initial antibiotic treatment. According to 
bacterial distribution characteristics and guidelines for 
hospital-acquired infection, antibiotics can be selected 
from third-generation or fourth-generation cephalosporins 
(cefoperazone, ceftazidime, cefepime) or β-lactams/β-lac-
tamase inhibitors (cefoperazone/sulbactam, piperacillin/
tazobactam). And if necessary, carbapenems (imipenem, 
meropenem) can be chosen.[17-18]
Prevention is the emphasis of hospital-acquired infec-
tion. Based on clinical experience and related literature re-
ports, 16 possible risk factors were included in this study. 
Given the possible mutual influence among these risk 
factors, single factor analysis was followed by multi-fac-
tor analysis to screen independent risk factors. The study 
has found that age, Ranson score and surgical treatment 
are three independent risk factors for SAP complicated by 
lung infection. First, as the patient ages, his/her immune 
globulin level and cellular immunity decline, resulting in 
decreased systemic resistance to infection. In addition, 
elderly patients’ capacity of sputum excretion weakens 
after operation. These systemic and local factors can 
make postoperative patients vulnerable to lung infections. 
Hence, elderly SAP patients should be the key population 
that needs to prevent lung infections. Second, Ranson 
score is a scoring standard that reflects the severity of 
pancreatitis recommended by most guidelines. The scor-
ing system includes 5 clinical indicators at admission and 
6 indicators in 48 hours. A score greater than 3 indicates 
severe pancreatitis, and the score is highly accurate in pre-
dicting organ failure and death. Our study has found that 
an increase in the Ranson score also means an increased 
risk of lung infection in SAP patients. Third, surgical de-
bridement plays an important role in the treatment of SAP, 
but due to the patient's systemic inflammatory response 
syndrome and the body’s poor state, there are various 
surgical complications and high mortality[19]. Abdominal 
incisions after debridement surgery can lead to difficulty 
in expectorating sputum and decreased breathing ability, 
which may give rise to lung infection. In recent years, 
minimally invasive debridement surgery of SAP has been 
valued. The progressive treatment of puncture, endoscopy, 
laparoscopy, and laparotomy can reduce postoperative 
complications and lower the lung infection rate from 50% 
to 27%[20].
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